Loading...
Last update:  May 26, 2023
08:28 +1GMT

Allergenic Molecule  Tri a 14Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
5.2.5 - Source Exposed, Children (Symptoms, IgE)2012FranceIgE8254.87020121030, Mameri H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2007SpainIgE4060.00020070822, Palacin A
6.5 - Occupational Exposure2011GermanyIgE402.50020110511, Sander I
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE352.86020130605, Simon D
4.1.3 - Heterologous Source Sensitized (SPT)2000ItalyIgE3411.8002000a, Asero R
5.2.1 - Source Exposed (Symptoms, SPT)2008SpainSPT31100.00020081216, Armentia A
6.5 - Occupational Exposure2012FranceIgE2951.72020121030, Mameri H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009SpainIgE2661.53020090526, Palacin A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2007SpainSPT2462.00020070822, Palacin A
5.3.1 - Source Exposed (Symptoms, IgE)2011Czech RepublicIgE2263.64020110531, Sotkovsky P
1.6 - Anaphylaxis, Diagnosed2013Korea, Republic ofIgE214.80020131122, Nam YH
5.2.4 - Source Exposed, Adults (Symptoms, IgE)2012FranceIgE2138.09020121030, Mameri H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012GermanyIgE175.88020120917, Hofmann SC
10.1 - Normal Control2012FranceIgE128.33020121030, Mameri H
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2011SpainIgE1190.90020110701, Tordesillas L
1.9 - Pollen Allergy2012FranceIgE1030.00020121030, Mameri H
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2011GermanyIgE1010.00020110511, Sander I
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2011SpainIgE988.88020110701, Tordesillas L
1.2 - Asthma, Diagnosed2013Korea, Republic ofIgE825.00020131122, Nam YH
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009SpainIgE8100.00020091217, Palacin A
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2011SpainIgE475.00020110701, Tordesillas L
Developed by
Panservice